MORE►
Paul Doman
Paul Dorman, Chairman and CEO of DFB Pharmaceuticals, assembled a team of internal and external experts after launching NanOlogy in a partnership with CritiTech and US Biotest in 2015. [Source photo: BioNTX]
BionorthTX Names Pharma Entrepreneur, Investor, and Philanthropist as Stone Award Recipient
by Lance Murray | Sep 9, 2019
Among the contributions of recipient Paul Dorman, the chairman and CEO of DFB Pharmaceuticals, is paying for the first-year tuition of the entire inaugural class of M.D. students at the TCU and UNTHSC School of Medicine in Fort Worth.
